Yong-xiang Chen

Calgary, AB, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Administration of the KCa channel activator SKA-31 improves long-term endothelial function, blood pressure regulation and cardiac performance in rats with type 2 diabetes.

Administration of the KCa channel activator SKA-31 improves long-term endothelial function, blood pressure regulation and cardiac performance in rats with type 2 diabetes.

Journal: Metabolism: clinical and experimental
Published: June 09, 2025

Roles of Brd4 in Vascular Smooth Muscle Cells: Implications for Aging and Vascular Dysfunction.

Roles of Brd4 in Vascular Smooth Muscle Cells: Implications for Aging and Vascular Dysfunction.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: May 22, 2025

Administration of the KCa channel activator SKA-31 improves endothelial function in the aorta of atherosclerosis-prone mice.

Administration of the KCa channel activator SKA-31 improves endothelial function in the aorta of atherosclerosis-prone mice.

Journal: Frontiers in pharmacology
Published: December 13, 2024

Pharmacological inhibition of MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) induces ferroptosis in vascular smooth muscle cells.

Pharmacological inhibition of MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) induces ferroptosis in vascular smooth muscle cells.

Journal: Cell death discovery
Published: August 17, 2023

Increased Ca2+ Transient Underlies RyR2-Related Left Ventricular Noncompaction.

Increased Ca2+ Transient Underlies RyR2-Related Left Ventricular Noncompaction.

Journal: Circulation research
Published: June 16, 2023

RyR2 Serine-2030 PKA Site Governs Ca2+ Release Termination and Ca2+ Alternans.

RyR2 Serine-2030 PKA Site Governs Ca2+ Release Termination and Ca2+ Alternans.

Journal: Circulation research
Published: December 30, 2022

Polo-like kinase 4 inhibitor CFI-400945 inhibits carotid arterial neointima formation but increases atherosclerosis.

Polo-like kinase 4 inhibitor CFI-400945 inhibits carotid arterial neointima formation but increases atherosclerosis.

Journal: Cell death discovery
Published: October 06, 2022

Accumulation of Plasma-Derived Lipids in the Lipid Core and Necrotic Core of Human Atheroma: Imaging Mass Spectrometry and Histopathological Analyses.

Accumulation of Plasma-Derived Lipids in the Lipid Core and Necrotic Core of Human Atheroma: Imaging Mass Spectrometry and Histopathological Analyses.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: September 02, 2021

HSP25 Vaccination Attenuates Atherogenesis via Upregulation of LDLR Expression, Lowering of PCSK9 Levels and Curbing of Inflammation.

HSP25 Vaccination Attenuates Atherogenesis via Upregulation of LDLR Expression, Lowering of PCSK9 Levels and Curbing of Inflammation.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: April 01, 2021

Unlike estrogens that increase PCSK9 levels post-menopause HSP27 vaccination lowers cholesterol levels and atherogenesis due to divergent effects on PCSK9 and LDLR.

Unlike estrogens that increase PCSK9 levels post-menopause HSP27 vaccination lowers cholesterol levels and atherogenesis due to divergent effects on PCSK9 and LDLR.

Journal: Pharmacological research
Published: July 27, 2020

Cardiac ryanodine receptor calcium release deficiency syndrome.

Cardiac ryanodine receptor calcium release deficiency syndrome.

Journal: Science translational medicine
Published: December 30, 2019

Inward Budding and Endocytosis of Membranes Regulated by de Novo Designed Peptides.

Inward Budding and Endocytosis of Membranes Regulated by de Novo Designed Peptides.

Journal: Langmuir : the ACS journal of surfaces and colloids
Published: May 08, 2018
Showing 1-12 of 21

Last Updated: 09/26/2026